Abstract
Heart failure is a progressive, lethal syndrome characterized by accelerating deterioration. Its estimated prevalence in the United States is around 2.0%, with an increased prevalence of 6–10% in patients >65 years old. The prognosis of heart failure is uniformly poor if the underlying problem cannot be rectified; half of all patients carrying a diagnosis of heart failure will die within 4 years, and in patients with severe heart failure more than 50% will die within 1 year. The actual rate of deterioration is highly variable and depends on the nature and causes of the overload, the age of the patient, and many other factors (Fig. 10.1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Swedberg K, Cleland J, Dargie H, et al.; Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-40
Hunt SA, Abraham WT, Chin MH, et al.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-235.
Katz AM. Heart Failure. Pathophysiology, Molecular Biology and Clinical Management. Philadelphia: Lippincott Williams and Wilkins; 2001.
Henein MY, Cailes J, O’Sullivan C, et al. Abnormal ventricular long-axis function in systemic sclerosis. Chest. 1995;108:1533-1540.
Fang ZY, Najos-Valencia O, Leano R, et al. Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol. 2003;42:446-453.
Kobayashi T, Tamano K, Takahashi M, et al. Myocardial systolic function of the left ventricle along the long axis in patients with essential hypertension: a study by pulsed tissue Doppler imaging. J Cardiol. 2003;41:175-182.
Klewer SE, Goldberg SJ, Donnerstein RL, et al. Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. J Am Coll Cardiol. 1992;19:394-401.
Mariotti E, Agostini A, Angelucci E, et al. Reduced left ventricular contractile reserve identified by low dose dobutamine echocardiography as an early marker of cardiac involvement in asymptomatic patients with thalassemia major. Echocardiography. 1996;13:463-472.
Ha JW, Lee HC, Kang ES, et al. Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography. Heart. 2007;93:1571-1576.
Kawano S, Ilda K, Fujeda K, et al. Response to isoproterenol as a prognostic indicator of evolution from hypertrophic cardiomyopathy to a phase resembling dilated cardiomyopathy. J Am Coll Cardiol. 1995;25:687-692.
Picano E. Diabetic cardiomyopathy. The importance of being earliest. J Am Coll Cardiol. 2003;42:454-457.
Neglia D, Parodi O, Gallopin M, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation. 1995;92:796-804.
Montisci R, Vacca A, Garau P, et al. Detection of early impairment of coronary flow reserve in patients with systemic sclerosis. Ann Rheum Dis. 2003;62:890-893.
Galderisi M, Capaldo B, Sidiropulos M, et al. Determinants of reduction of coronary flow reserve in patients with type 2 diabetes mellitus or arterial hypertension without angiographically determined epicardial coronary stenosis. Am J Hypertens. 2007;20:1283-1290.
Bartel T, Yang Y, Müller S, et al. Noninvasive assessment of microvascular function in arterial hypertension by transthoracic Doppler harmonic echocardiography. J Am Coll Cardiol. 2002;39:2012-2018.
Agricola E, Oppizzi M, Pisani M, et al. Stress echocardiography in heart failure. Cardiovasc Ultrasound. 2004;2:11.
Neskovic AN, Otasevic P. Stress-echocardiography in idiopathic dilated cardiomyopathy: instructions for use. Cardiovasc Ultrasound. 2005;3:3.
Nagaoka H, Isobe N, Kubota S, et al. Myocardial contractile reserve as prognostic determinant in patients with idiopathic dilated cardiomyopathy without overt heart failure. Chest. 1997;111:344-350.
Paelinck B, Vermeersch P, Stockman D, et al. Usefulness of low-dose dobutamine stress echocardiography in predicting recovery of poor left ventricular function in atrial fibrillation dilated cardiomyopathy. Am J Cardiol. 1999;83:1668-1671.
Naqvi TZ, Goel RK, Forrester JS, et al. Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1999;34:1537-1544.
Kitaoka H, Takata J, Yabe T, et al. Dobutamine stress echocardiography can predict the improvement of left ventricular systolic function in dilated cardiomyopathy. Heart. 1999;81:523-527.
Scrutinio D, Napoli V, Passantino A, et al. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome. Eur Heart J. 2000;21:927-934.
Paraskevaidis IA, Adamopoulos S, Kremastinos DT. Dobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption: 18-month follow-up study. J Am Coll Cardiol. 2001;37:1685-1691.
Pratali L, Picano E, Otasevic P, et al. Prognostic significance of dobutamine echocardiography test in idiopathic dilated cardiomyopathy. Am J Cardiol. 2001;88:1374-1378.
Pinamonti B, Perkan A, Di Lenarda A, et al. Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications. Eur J Heart Fail. 2002;4:49-61.
Drozdz J, Krzeminska-Pakula M, Plewka M, et al. Prognostic value of low-dose dobutamine echocardiography in patients with idiopathic dilated cardiomyopathy. Chest. 2002;121:1216-1222.
Otasevic P, Popovic ZB, Vasiljevic JD, et al. Head-to-head comparison of indices of left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in idiopathic dilated cardiomyopathy: five-year follow up. Heart. 2006;92:1253-1258.
Williams MJ, Odabashian J, Lauer MS, et al. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol. 1996;27:132-139.
Marron A, Schneeweiss A. Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol. 1997;29:422-428.
Pratali L, Otasevic P, Rigo F, et al. The additive prognostic value of restrictive pattern and dipyridamole-induced contractile reserve in idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2005;7:844-851.
Pratali L, Otasevic P, Neskovic A, et al. DIP Prognostic value of pharmacologic stress echocardiography in patients with idiopathic dilated cardiomyopathy: a prospective, head-to-head comparison between dipyridamole and dobutamine test. J Card Fail. 2007;13:836-842.
Rigo F, Gherardi S, Galderisi M, et al. The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in non-ischaemic dilated cardiomyopathy. Eur Heart J. 2006;27:1319-1323.
Rigo F, Richieri M, Pasanisi E, et al. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol. 2003;91:269-273.
Pinamonti B, Zecchin M, Di Lenarda A, et al. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol. 1997;29:604-612.
Frassi F, Gargani L, Tesorio P, et al. Prognostic value of extravascular lung water assessed with ultrasound lung comets by chest sonography in patients with dyspnea and/or chest pain. J Card Fail. 2007;13:830-835.
Sharp SM, Sawada SG, Segar DS, et al. Dobutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. J Am Coll Cardiol. 1994;24:934-939.
Vigna C, Russo A, De Rito V, et al. Regional wall motion analysis by dobutamine stress echocardiography to distinguish between ischemic and non-ischemic dilated cardiomyopathy. Am Heart J. 1996;131:537-543.
Cohen A, Chauvel C, Benhalima B, et al. Is dobutamine stress echocardiography useful for noninvasive differentiation of ischemic from idiopathic dilated cardiomyopathy? Angiology. 1997;48:783-793.
Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151-1158.
Galderisi M, Cattaneo F, Mondillo S. Doppler echocardiography and myocardial dyssynchrony: a practical update of old and new ultrasound technologies. Cardiovasc Ultrasound. 2007;5:28.
Gorcsan J III, Abraham T, Agler DA, et al.; American Society of Echocardiography Dyssynchrony Writing Group. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr. 2008;21:191-213.
Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;2008(117):2608-2616.
Da Costa A, Thévenin J, Roche F, et al. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders. Heart Rhythm. 2006;3:406-413.
Ciampi Q, Pratali L, Citro R, et al (2009) Identification of responders to CRT by stress echo: no contractile reserve, no party. Eur J Heart Failure. 2009;11:489-496.
Jourdain P, Funck F, Fulla Y, et al. Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol. Eur J Heart Fail. 2002;4:269-276.
Schwammenthal E, Vered Z, Moshkowitz Y, et al. Dobutamine echocardiography in patients with aortic stenosis and left ventricular dysfunction: predicting outcome as a function of management strategy. Chest. 2001;119:1766-1777.
Ciampi Q, Villari B. Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction. Cardiovasc Ultrasound. 2007;5:34.
Acknowledgement
Reproduced from Picano E, Stress echocardiography, Fifth edition, Springer, Berlin, 2009.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer London
About this chapter
Cite this chapter
Picano, E. (2010). Stress Echocardiography. In: Henein, M. (eds) Heart Failure in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-84996-153-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-84996-153-0_10
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84996-152-3
Online ISBN: 978-1-84996-153-0
eBook Packages: MedicineMedicine (R0)